HIGHLIGHTS
- who: Bernarda Majc and collaborators from the Brown University, United States have published the research: Bioactive peptides from venoms against glioma progression, in the Journal: (JOURNAL)
SUMMARY
Biologically and pharmacologically active peptides, hereafter referred to as "bioactive peptides," are usually 2-20 amino_acid residues (AA) long, although some have been reported to be longer. GB stem_cells (GSCs) are the second factor responsible for the high therapy resistance of GB. Various molecular targets have been proposed to be related to the effect of venom peptides on GB, including ion_channels, integrins and membrane phospholipids. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.